Diagnostic Products Corporation Schedules Conference Call to Discuss Third Quarter 2005 Results

Diagnostic Products Corporation (NYSE:DP) announced
today that it has scheduled a conference call to discuss the Company's
financial results of its third quarter 2005 on Monday, October 24,
2005, at 11:30 a.m. Eastern daylight time (8:30 a.m. PDT).
   The Company plans to release its financial results before the
market opens on Monday.
   If you are interested in participating in the call, please call
800-268-8047 on the day of the conference, at least ten minutes prior
to the conference in order for the operator to tie you into the call.
The operator will ask you to identify the call with the company name
Diagnostic Products Corporation-Jim Brill.
   An "instant replay" of the call will be available until November
4. If you would like to take advantage of this special service, you
can access it via 800-839-6713 and the code: "7443480." It usually
takes two hours following the conference to set up the recording.

   About Diagnostic Products Corporation

   Diagnostic Products Corporation, founded in 1971, is a global
leader dedicated to immunodiagnostics. DPC's product menu includes
over 75 immunoassays and more than 375 specific allergens and allergy
panels. In addition, DPC addresses the chemistry and laboratory
automation testing needs of its customers through partnerships with
manufacturers of chemistry systems and reagents. The combined
chemistry and immunoassay menu is one of the largest and most
diversified available, covering most laboratory tests requested. DPC
also designs and manufactures automated laboratory instrumentation,
which provides fast, accurate results while reducing labor and reagent
costs. DPC sells its products to hospitals, clinics and laboratories
in more than 100 countries. Additional Company information can be
found on DPC's website at www.dpcweb.com.

   Except for the historical information contained herein, this press
release contains forward-looking statements that involve risks and
uncertainties that could cause actual results to differ materially.
These factors include governmental or other action relating to the
Company's Chinese affiliate; the rate of customer demand for the
Company's products; the Company's ability to successfully market new
and existing products; its dependence on certain suppliers; domestic
and foreign government regulation; its ability to keep abreast of
technological innovations and to translate them into new products;
competition; political and economic instability in certain markets
including the movements of foreign currencies relative to the dollar;
and other risks and uncertainties disclosed from time to time in the
Company's SEC reports and filings.